Live News EQUITY FLASH M impact Nov 13, 2026, 10:55 PM UTC Corvus Pharmaceuticals Officer Acquires 4,500 Shares for $50,475.215 Chief Business Officer Jeffrey Arcara acquired 4,500 common shares for $50,475.215. CRVS SquawkNews Desk